In a move that underscores their commitment to bolstering bullpen depth, the Chicago Cubs have re-signed right-handed reliever Yency Almonte to a minor-league deal. This reunion comes after Almonte’s brief but impactful stint with the team in 2024, during which he showcased his potential before an injury sidelined him for the remainder of the season.
Almonte’s Initial Tenure with the Cubs
Almonte, 30, joined the Cubs in January 2024 as part of a trade with the Los Angeles Dodgers that also brought infielder Michael Busch to Chicago. In exchange, the Cubs sent minor league prospects Jackson Ferris and Zyhir Hope to Los Angeles. citeturn0search0 Prior to his injury, Almonte made 17 appearances for the Cubs, posting a 3.45 ERA, a 3.36 FIP, and a 1.09 WHIP over 15 2/3 innings. He recorded 20 strikeouts against eight walks, holding opposing hitters to a .158 batting average (.199 xBA). His performance earned him a role in high-leverage situations, particularly in the seventh and eighth innings.
The Impact of Injury
Almonte’s promising season was abruptly halted due to a shoulder injury that required surgery in June 2024. This development was a significant blow to the Cubs’ bullpen, which had already been navigating challenges throughout the season. Despite his limited time on the mound, Almonte’s contributions were notable, and his absence was felt as the team sought stability in its relief corps.
The Decision to Re-Sign
The Cubs’ decision to bring Almonte back on a minor-league deal reflects a strategic approach to enhancing bullpen depth without significant financial commitments. Given Almonte’s previous success and familiarity with the organization, this move presents a low-risk, high-reward scenario. If Almonte returns to form post-recovery, he could provide the Cubs with a reliable bullpen option, addressing one of the team’s critical needs from the previous season.
Almonte’s Career Trajectory
Almonte’s professional journey has been characterized by resilience and adaptability. Debuting with the Colorado Rockies in 2018, he accumulated a 4.51 ERA over 196 appearances, with 195 strikeouts and 87 walks across 207.1 innings. His tenure with the Dodgers in 2022 was particularly impressive, as he posted a 1.02 ERA over 33 appearances, establishing himself as a formidable bullpen asset. However, injuries have intermittently disrupted his momentum, making his health a focal point for the Cubs moving forward.
The Cubs’ Bullpen Outlook
The 2024 season highlighted the Cubs’ bullpen vulnerabilities, with several relievers departing due to free agency or performance issues. The losses of Jorge López, Drew Smyly, Adbert Alzolay, and Trey Wingenter created a void that the team has been eager to fill. While additions like Eli Morgan, Brooks Kriske, and Phil Bickford have been made, the bullpen still requires experienced arms capable of handling high-pressure situations. Almonte’s return aligns with the Cubs’ strategy of signing relievers to minor-league deals, providing flexibility and potential upside.
Looking Ahead
As Spring Training approaches, all eyes will be on Almonte’s recovery and performance. His ability to regain his pre-injury form could significantly influence the composition and effectiveness of the Cubs’ bullpen in the upcoming season. For Almonte, this opportunity represents a chance to reestablish himself as a dependable reliever and contribute meaningfully to the Cubs’ pursuit of postseason success.
In conclusion, the Cubs’ decision to re-sign Yency Almonte reflects a calculated effort to strengthen their bullpen by investing in a player with proven potential. If Almonte can overcome his injury setbacks and return to his previous performance levels, this reunion could prove mutually beneficial, bolstering the Cubs’ relief options while providing Almonte with a platform to showcase his resilience and skill.
